These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3710619)

  • 1. Sporadic somatic fusion between MDAY-D2 murine tumor cells and DBA/2 host cells: role in metastasis.
    Lagarde AE
    Int J Cancer; 1986 Jun; 37(6):905-10. PubMed ID: 3710619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous fusion in vivo between normal host and tumor cells: possible contribution to tumor progression and metastasis studied with a lectin-resistant mutant tumor.
    Kerbel RS; Lagarde AE; Dennis JW; Donaghue TP
    Mol Cell Biol; 1983 Apr; 3(4):523-38. PubMed ID: 6687920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suggestive evidence that the highly metastatic variant ESb of the T-cell lymphoma Eb is derived from spontaneous fusion with a host macrophage.
    Larizza L; Schirrmacher V; Graf L; Pflüger E; Peres-Martinez M; Stöhr M
    Int J Cancer; 1984 Nov; 34(5):699-707. PubMed ID: 6500746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogenicity of tumor cell populations: origin of a putative H-2 isoantigenic loss variant tumor.
    Kerbel RS; Florian M; Man MS; Dennis J; McKenzie IF
    J Natl Cancer Inst; 1980 May; 64(5):1221-30. PubMed ID: 6929020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive immune therapy in mice bearing poorly immunogenic metastases, using T lymphocytes stimulated in vitro against highly immunogenic mutant sublines.
    Dennis JW; Laferté S; Man MS; Elliott BE; Kerbel RS
    Int J Cancer; 1984 Nov; 34(5):709-16. PubMed ID: 6437992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial reversion of the metastatic phenotype in a wheat germ agglutinin-resistant mutant of the murine tumor cell line MDAY-D2 selected with Bandeiraea simplicifolia seed lectin.
    Dennis JW
    J Natl Cancer Inst; 1985 May; 74(5):1111-20. PubMed ID: 3858579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inheritance of immunogenicity and metastatic potential in murine cell hybrids from the T-lymphoma ESb08 and normal spleen lymphocytes.
    Larizza L; Schirrmacher V; Stöhr M; Pflüger E; Dzarlieva R
    J Natl Cancer Inst; 1984 Jun; 72(6):1371-81. PubMed ID: 6610070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of a tumor with greatly increased metastatic growth potential by injection of cells from a low-metastatic H-2 heterozygous tumor cell line into an H-2 incompatible parental strain.
    Kerbel RS; Twiddy RR; Robertson DM
    Int J Cancer; 1978 Nov; 22(5):583-94. PubMed ID: 721318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquisition of high metastatic capacity after in vitro fusion of a nonmetastatic tumor line with a bone marrow-derived macrophage.
    Larizza L; Schirrmacher V; Pflüger E
    J Exp Med; 1984 Nov; 160(5):1579-84. PubMed ID: 6491605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoconjugates of murine tumor lines with different metastatic capacities. II. Diversity of glycolipid composition.
    Schwartz R; Kniep B; Müthing J; Mühlradt PF
    Int J Cancer; 1985 Nov; 36(5):601-7. PubMed ID: 4055130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fluctuation analysis of the rate of reexpression of the metastatic potential in a nonmetastatic mutant of the MDAY-D2 murine tumor.
    Lagarde AE
    Invasion Metastasis; 1983; 3(1):52-64. PubMed ID: 6677620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic studies of membrane mutants of a highly metastatic murine tumor.
    Kerbel RS
    Am J Pathol; 1979 Dec; 97(3):609-22. PubMed ID: 507193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
    Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S
    J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-mediated arrest and reversal of established visceral metastases in athymic mice.
    Wiltrout RH; Frost P; Morrison MK; Kerbel RS
    Cancer Res; 1979 Oct; 39(10):4034-41. PubMed ID: 476640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosphingolipids of lectin-resistant mutants of the highly metastatic mouse tumor cell line, MDAY-D2.
    Laferté S; Fukuda MN; Fukuda M; Dell A; Dennis JW
    Cancer Res; 1987 Jan; 47(1):150-9. PubMed ID: 3791202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoselection in vitro of a non-metastatic variant from a highly metastatic tumor.
    Frost P; Kerbel RS
    Int J Cancer; 1981 Mar; 27(3):381-5. PubMed ID: 7287222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity.
    Driessens MH; Stroeken PJ; Rodriguez Erena NF; van der Valk MA; van Rijthoven EA; Roos E
    J Cell Biol; 1995 Dec; 131(6 Pt 2):1849-55. PubMed ID: 8557751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in sensitivity to nonspecific cell-mediated lysis associated with tumor progression: characterization of activated macrophage- and natural killer cell-resistant tumor variants.
    Nestel FP; Casson PR; Wiltrout RH; Kerbel RS
    J Natl Cancer Inst; 1984 Aug; 73(2):483-91. PubMed ID: 6589440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of in vitro immunoselected variants from a highly metastatic murine tumor for alterations in malignant behavior in vivo.
    Liteplo RG; Frost P; Donaghue TP; Kerbel RS
    Int J Cancer; 1984 May; 33(5):669-75. PubMed ID: 6724741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic and phenotypic evolution of a murine tumor during its progression in vivo toward metastasis.
    Lagarde AE; Donaghue TP; Dennis JW; Kerbel RS
    J Natl Cancer Inst; 1983 Jul; 71(1):183-91. PubMed ID: 6575202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.